| Literature DB >> 33790288 |
Christopher Ludtka1, Justin Silberman2, Erika Moore2, Josephine B Allen3.
Abstract
The effects of a microgravity environment on the myriad types of immune cells present within the human body have been assessed both by bench-scale simulation and suborbital methods, as well as in true spaceflight. Macrophages have garnered increased research interest in this context in recent years. Their functionality in both immune response and tissue remodeling makes them a unique cell to investigate in regards to gravisensitive effects as well as parameters of interest that could impact astronaut health. Here, we review and summarize the literature investigating the effects of microgravity on macrophages and monocytes regarding the microgravity environment simulation/generation methods, cell sources, experiment durations, and parameters of interest utilized within the field. We discuss reported findings on the impacts of microgravity on macrophage/monocyte structure, adhesion and migration, proliferation, genetic expression, cytokine secretion, and reactive oxygen species production, as well as polarization. Based on this body of data, we make recommendations to the field for careful consideration of experimental design to complement existing reports, as the multitude of disparate study methods previously published can make drawing direct comparisons difficult. However, the breadth of different testing methodologies can also lend itself to attempting to identify the most robust and consistent responses to microgravity across various testing conditions.Entities:
Year: 2021 PMID: 33790288 PMCID: PMC8012370 DOI: 10.1038/s41526-021-00141-z
Source DB: PubMed Journal: NPJ Microgravity ISSN: 2373-8065 Impact factor: 4.415
Fig. 1Representative examples of experimental methods used to simulate microgravity.
Panels a, b show digital images of a rotating wall vessel (RWV) bioreactor. Here vascular cells are grown in culture chambers which are then rotated concentrically around a single axis. Panel c shows a RPM with two independently driven perpendicular frames[83]. Panel d shows the parabolic flight trajectory[84] used to create short-duration microgravity exposure.
Summary of major macrophage cell sources used in microgravity experiments.
| Cell type | Description |
|---|---|
| Primary macrophages/monocytes | Cells harvested and isolated from living tissue samples, such as blood or immune cell-rich organs (e.g., bone marrow, spleen) |
| RAW 264.7 cells | Murine macrophage-like cell line from an Abelson murine leukemia in BALB/c mice |
| U937 cells | Human leukemic myelomonocytic cell line that differentiates into a macrophage-like phenotype |
| NR8383 cells | Rat alveolar macrophage cell line isolated from lung tissue |
| B6MP102 cells | Murine bone marrow-derived macrophage factor-dependent cell line |
| J-111 cells | Human acute monocytic leukemia cell line, but contaminated with HeLa cells (HPV-related endocervical adenocarcinoma) |
Outline of experimental platforms, cell types, durations, and results in the literature of macrophage microgravity research.
| Experiment platform | Paper | Cell type | Time in µg | Results |
|---|---|---|---|---|
| Clinorotation (simulated µg) | Shi 2020 | Primary mouse | 12 d | Macrophage differentiation from hematopoietic progenitor cells and functional polarization impaired in µg; RAS/ERK/NFκB pathway gravisensitive |
| Wang 2015 | Primary mouse | 24 h | Simulated µg activates p38 MAPK-C/EBPβ pathway; increased arginase expression; upregulated IL-6, downregulated IL-12B | |
| Brungs 2015 | NR8383 | 4 h | Reduced ROS production in µg; diminished Syk phosphorylation; NFκB nuclear translocation unaltered | |
| Paulsen 2015 | BV-2 microglial cells; U937; Primary human | 1 d; 3 d; 5 d | Reduced ICAM-1 expression in BV-2 cells; increased ICAM-1 expression in U937 and primary human macrophages | |
| Wang 2014 | RAW 264.7; Primary mouse | 24 h | LPS-induced TNF-α expression in µg reduced, but not IL-1β; increased HSF-1 in µg; nuclear translocation of NFκB unchanged | |
| Adrian 2013 | NR8383 | 30–180 m | ROS release is reduced in µg, responding rapidly and reversibly | |
| Paulsen 2010 | U937 | 5 m | Non-stimulated macrophages had enhanced tyrosine phosphorylation and c-jun activation; PMA-stimulated macrophages had reduced tyrosine phosphorylation and c-jun activation | |
| Maier 2006 | U937 | 24 h; 72 h | Upregulation of hsp70; inhibited proliferation; altered cytokine secretion in µg | |
| Hsieh 2005 | RAW 264.7 | 2 d | Reduction in nitric oxide and cytokine production; flavonoids compensated for loss of macrophage function in 3D culture | |
| Maccarrone 2003 | U937 | 2–72 h | No expression of active 5-LOX or apoptosis, in contrast to lymphocytes | |
| Hashemi 1999 | Primary human | 24 h | Normal IL-1 synthesis | |
| Random position machine (simulated µg) | Meloni 2006 | J-111 | 1 h; 24 h | Cell motility severely reduced in µg; actin, tubulin, and vinculin structures affected |
| Limb suspension (simulated µg) | Liu 2015 | Primary rat | 28 d | µg increased monocyte recruitment, E-selectin and MCP-1 expression, and NFκB activation in abdominal aorta |
| Suborbital/sounding rocket (real µg) | Thiel 2019 | Primary Human | 353 s | µg induces cell geometry changes, rapid cytoskeleton reorganization, and rapid adaptation of the cytoskeleton |
| Vogel 2019 | U937 | 300 s | HIF-1 differently regulated in altered gravity; some genes have rapid response and adaptation, others altered only after 5 min. in µg | |
| Thiel 2018 | U937 | 300 s | Transcriptome greatly altered in µg; 99.43% of all initially altered transcripts adapted after 5 min. | |
| Paulsen 2015 | U937 | 378 s | No detectable effect on ICAM-1 mRNA expression | |
| Parabolic flight (real µg) | Vogel 2019 | U937 | 20 s | HIF-1 differently regulated in altered gravity; some genes have rapid response and adaptation, others altered only after 5 min. in µg |
| Thiel 2018 | U937 | 20 s | Transcriptome greatly altered in µg; 99.43% of all initially altered transcripts adapted after 5 min. | |
| Paulsen 2015 | BV-2 microglial cells; U937; Primary human | 20 s | Rapid, reversible downregulation of ICAM-1 in BV-2 cells; upregulation of ICAM-1 in differentiated U937 cells; Primary human inconclusive | |
| Adrian 2013 | NR8383 | 22 s | ROS release is reduced in µg, responding rapidly and reversibly | |
| Paulsen 2010 | U937 | 20 s | 1.3-fold increased MEK phosphorylation; rapid p53 phosphorylation in non-stimulated U937 cells | |
| Armstrong 1995 | B6MP102 | 20 s | Macrophages respond to µg within 8 s, with increased cell spreading | |
| Spaceflight (real µg) | Shi 2020 | Primary mouse | 12 d | Macrophage differentiation from hematopoietic progenitor cells and functional polarization impaired in µg; RAS/ERK/NFκB pathway gravisensitive |
| Tauber 2017 | Primary human | 11 d; 30 d | Decreased ICAM-1 and surface-bound fucose; CD18 and CD14 surface expression unaltered | |
| Thiel 2017 | NR8383 | 15 m | Immediate oxidative burst inhibition followed by extremely rapid adaptation to µg | |
| Paulsen 2015 | U937 | 5 d | Upregulation of ICAM-1 in differentiated U937 cells | |
| Paulsen 2014 | U937 | 5 d | Disturbed actin, disorganized tubulin, and reduced CD18, CD36, MHC-II expression in µg | |
| Crucian 2011 | Primary human (blood sample) | 13–16 d | Inflammatory phenotype and cytokine production impacted by spaceflight; LPS-stimulated cells showed reduced IL-6, TNF-α, IL-10, and increased IL-1b in µg | |
| Meloni 2011 | J-111 | 24 h | Severe reduction in motility attributed to disruption of cytoskeleton; actin, tubulin, vinculin distribution affected | |
| Baqai 2009 | Primary mouse (spleen sample) | 13 d | Spaceflight can increase anti-inflammatory mechanisms; altered response to LPS stimulation; reduced monocyte/macrophage count; upregulated ROS genes post-flight | |
| Kaur 2005 | Primary human (blood sample) | 5–11 d | Monocytes had reduced phagocytic ability, oxidative burst, and degranulation after spaceflight | |
| Hatton 1999 | U937 | 9 d | Kinetics of protein kinase C are modified during spaceflight. | |
| Chapes 1999 | Primary rat (peritoneal sample) | 10 d | Enhanced secretion of TNF, IL-6, and nitric oxide | |
| Hashemi 1999 | Primary human | 22 h; 25 h | Normal IL-1 synthesis | |
| Armstrong 1995 | B6MP102 | 6–8 d | Increased macrophage proliferation; reduced IL-6 secretion; reduced differentiation | |
| Chapes 1992 | B6MP102 | 6 d; 9 d | Greater secretion of IL-1 and TNF of LPS-stimulated macrophages in µg |
µg microgravity, s second, m minute, h hour, d day.